Delivery Order SPE2DR25D2007-SPE2DR26FM49M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $55,197.07 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $12,033.07 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 22, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,259.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package) on January 21, 2026, with ultimate completion by January 22, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $35,821.40 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT (orally disintegrating tablet) 4mg in a 30-count package. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 7, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $15,452.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8 mg tablets (30-count units), with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $32,253.76 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8mg tablets in a 30-count package. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 4, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $31,740.85 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages). This competitively awarded, firm fixed-price delivery order was issued on January 9, 2026, with an ultimate completion date of January 12, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects open competition in the...
- The Defense Logistics Agency awarded a delivery order valued at $5,799.91 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. This firm fixed-price contract was awarded on January 26, 2026, with an ultimate completion date of January 27, 2026, and represents a non-competitive delivery order issued under an existing contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,579.60 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) on January 23, 2026, with completion expected by January 26, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication for managing nausea...
- The Defense Logistics Agency awarded a delivery order valued at approximately $26,000 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with completion expected by July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM49MDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $36,633.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 29, 2026, with completion expected by January 30, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. Ondansetron is an antiemetic medication commonly used in military and federal healthcare systems to prevent nausea and vomiting in various clinical settings. AmerisourceBergen serves as a critical pharmaceutical vendor for federal medical procurement, supplying medications across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other government healthcare systems. The parent IDC vehicle enables efficient ordering and delivery of essential pharmaceutical commodities to sustain federal medical operations globally, with this particular delivery order representing routine pharmaceutical replenishment within that comprehensive supply framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.6k | 1/28/26 |